Information Provided By: 
Fly News Breaks for October 23, 2015
VRX, JAZZ, HZNP, ENDP
Oct 23, 2015 | 07:52 EDT
Stifel notes that the specialty pharma group has fallen nearly 20% since the media began reporting about price gouging by the sector. The firm says that the group's fundamentals haven't changed, while its valuation has reached the lowest level since 2009, when its business models and fundamentals were far inferior to today. The firm says that it may take "multiple quarters" for the group to show that its fundamentals are intact. Endo (ENDP) ,Horizon Pharma (HZNP) Jazz Pharmaceuticals (JAZZ), and Valeant (VRX) are among the name in the sector.
News For ENDP;HZNP;JAZZ;VRX From the Last 2 Days
There are no results for your query ENDP;HZNP;JAZZ;VRX
